|
⚲
|
| Keyboard |
| Celgene Switzerland LLC
✚
|
|
|---|---|
| CIK # | 0001661486 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001661486] | |
| 4 | [0001661486] | |
| SC 13G | [0001661486] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Celgene Switzerland LLC | Jounce Therapeutics Inc | [2017-02-10] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2019-11-12 | Buy | 403,225 | $31.00 | 12,499,975 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2018-01-23 | Buy | 851,154 | $67.00 | 57,027,318 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2017-04-24 | Buy | 624,575 | $49.50 | 30,916,462 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2017-02-01 | Conversion | 2,831,463 | ||
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2017-02-01 | Buy | 625,000 | $16.00 | 10,000,000 |
|
Jounce Therapeutics Inc JNCE
Series B-1 Preferred Stock · derivative
|
2017-02-01 | Conversion | 10,448,100 | $0.00 |